Kemal Yar

Kemal Yar

Auto-generated profile, based on publicly available information

Kemal Yar

Cukurova Universıty

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2011 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
MYMeltem Yagmur
Meltem Yagmur
OOOkan Okay
Okan Okay
SSSelcuk Sizmaz
Selcuk Sizmaz
IUIlker Unal
Ilker Unal
KYKemal Yar
Kemal Yar

29 June 2020 in European Journal of Therapeutics
Verified
Journal Article
Open access
KYKemal Yar
Kemal Yar
AOAltan A. Ozcan
Altan A. Ozcan
YKYURDUN KUYUCU
YURDUN KUYUCU
SESeyda Erdogan
Seyda Erdogan
SPSait Polat
Sait Polat
Topical mitomycin C,Cornea,Toxic effect

5 January 2014 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
EEEbru Esen
Ebru Esen
EEElif Erdem
Elif Erdem
KYKemal Yar
Kemal Yar
NDNihal Demircan
Nihal Demircan
MSMerih Soylu
Merih Soylu
Objectives: To determine the rate of infants with retinopathy of prematurity (ROP) requiring treatment, to investigate the relation of\ud this rate with birth age and birth weight, and to discuss the screening criteria eligible for our country.\ud Materials and Methods: Medical records of premature infants examined for ROP with birth weight ≤2000 gram (g) and/or\ud gestational age ≤34 weeks were evaluated. Patients were grouped according to their birth weights as ≤1000 g, 1001-1500 g, >1500\ud g, and according to gestational age as ≤27 weeks, 28-31 weeks, ≥32 weeks. The rate of patients with treatment-requiring ROP was\ud evaluated in these groups. The birth weights and gestational ages of these patients were analyzed.\ud Results: Treatment requiring ROP stages were detected in 100 (8%) of 1250 infants. The mean gestational age and birth weight\ud of these patients was 28.3±2.3 (24-34) weeks and 1152.2±396 (520-2120) g respectively, and both were found lower than those of\ud nontreated infants (p1500 g required treatment. According to the gestational age, 33 (19.4%) of 170 infants ≤27 weeks,\ud 59 (10.3%) of 572 infants between 28-31 weeks, 8 (1.6%) of 508 infants ≥32 weeks required treatment.\ud Conclusion: The best way to avoid the vision loss due to ROP is to establish a regular screening program including every infant that\ud may require treatment. So we recommend that screening criteria for our country should be wider than applied in developed countries, and\ud babies having gestational age ≤34 weeks and/or birth weight ≤2000 g should be screened for ROP. (Turk J Ophthalmol 2014; 44: 42-6